RUMORED BUZZ ON GW3965 HYDROCHLORIDE

All enrolled people who obtained no less than 1 dose of zosuquidar or placebo all through induction had been monitored to the incidence of adverse situations (439 individuals, 219 on zosuquidar and 210 on placebo). The most typical adverse functions ended up related to the duration of extended and sizeable myelosuppression as is expected with induc